Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines.

Clinical and experimental rheumatology(2022)

引用 1|浏览7
暂无评分
摘要
Obesity influences the extent of LDA/remission in patients treated with TNFi, but not in patients treated with TCZ, probably because of underlying pathophysiological mechanisms intrinsic to the production of proinflammatory adi-pokines. Therefore, therapeutic strategies with a mechanism of action other than TNF inhibition would be more suitable for obese patients.
更多
查看译文
关键词
rheumatoid arthritis,obesity,adipokines,tumour necrosis factor inhibitors,tocilizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要